10:25 AM EST - Ventripoint Diagnostics Ltd : Announced several strategic initiatives to strengthen its balance sheet and accelerate commercialization of its proprietary AI-enabled echocardiography technology that is cleared for sale in the US, Canada, EU and UK. These initiatives include: the closing of the first tranche of a $350,000 non-brokered private placement of Units, the engagement of More Capital Ltd. as strategic growth advisor, and the engagement of Red Cloud Securities Inc. as market maker. Ventripoint Diagnostics Ltd
shares V.VPT are trading unchanged at $0.10.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=VPT%3ACC&qmodStoryID=4574677121864370
